Figures & data
Figure 1. Immunohistochemistry analysis expression of VEGF in the endometrium and myometrium at adenomyosis. IHC MAT to VEGF, original magnification 80×.
![Figure 1. Immunohistochemistry analysis expression of VEGF in the endometrium and myometrium at adenomyosis. IHC MAT to VEGF, original magnification 80×.](/cms/asset/ecebb5b6-c3ad-4d83-a9e0-aaa3e15e2d60/igye_a_1232902_f0001_c.jpg)
Figure 2. Immunohistochemistry analysis of VEGF Expression in the myometrium of patients with chronic pelvic pain caused by adenomyosis. A weak reaction to MAT for VEGF in the cytoplasm of smooth myocytes and intense reaction in the cells of the perivascular compartment. IHC MAT to VEGF, original magnification 200×.
![Figure 2. Immunohistochemistry analysis of VEGF Expression in the myometrium of patients with chronic pelvic pain caused by adenomyosis. A weak reaction to MAT for VEGF in the cytoplasm of smooth myocytes and intense reaction in the cells of the perivascular compartment. IHC MAT to VEGF, original magnification 200×.](/cms/asset/4ada4724-7863-41c0-895b-74cbc95a3ecd/igye_a_1232902_f0002_c.jpg)
Figure 3. Immunohistochemistry analysis of VEGF Expression in the walls of venous vessels in areas of myometrium remodeling in patients with adenomyosis. IHC MAT to VEGF, original magnification 80×.
![Figure 3. Immunohistochemistry analysis of VEGF Expression in the walls of venous vessels in areas of myometrium remodeling in patients with adenomyosis. IHC MAT to VEGF, original magnification 80×.](/cms/asset/72844a8c-177c-4d0e-832e-9a881f531894/igye_a_1232902_f0003_c.jpg)